
Originally published bySouth China Morning Post
China has unveiled an artificial intelligence platform for drug discovery that can screen a vast library of chemical compounds, cutting the initial drug screening phase from months or years down to tens of seconds.
Developers said they expected the system to provide a novel method for identifying lead molecules to treat tumours, neurodegenerative conditions, rare diseases and emerging infectious diseases, as well as possibly speeding up drug research during public health crises.
Called GalaxyVS,...
๐จ๐ณ
More news from ChinaChina
ASIA
Related News

Iran says does not trust US as Trump toughens terms
7h ago

Two patients with Ebola-like symptoms in isolation in Brazil
2h ago

Myanmarโs China-backed mega dam revival risks Kachin rebel backlash
3h ago

Capturing Beaufort 'dramatic shift' in Lebanon offensive โ Israel PM
3h ago

Chinese EV makers shift focus from price wars to AI capability: Morgan Stanley
4h ago